Repurposing Quinoline and Artemisinin Antimalarials as Therapeutics for SARS-CoV-2: Rationale and Implications

[Image: see text] The coronavirus disease-2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has infected more than 116 million individuals globally and resulted in over 2.5 million deaths since the first report in December 2019. For most of this time,...

Descripción completa

Detalles Bibliográficos
Autores principales: Firestone, Tessa M., Oyewole, Opeoluwa O., Reid, St Patrick, Ng, Caroline L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009099/
https://www.ncbi.nlm.nih.gov/pubmed/33855275
http://dx.doi.org/10.1021/acsptsci.0c00222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009099/
https://www.ncbi.nlm.nih.gov/pubmed/33855275
http://dx.doi.org/10.1021/acsptsci.0c00222

Ejemplares similares